Skip to main content

Government’s contracts with Randox Laboratories Ltd

Inquiry

At the start of the pandemic Government had to rapidly create high volume COVID-19 testing capacity, but the National Audit Office (NAO) has found that, even taking the exceptional circumstances into account, “the documentation of the decision-making process for such large contracts was inadequate”, and Government did “not document key decisions adequately when awarding a contract to Randox Laboratories Ltd (Randox) for testing services”.

The gaps in the audit trail mean the NAO was “not able to provide positive assurance in the normal way, but has not seen any evidence that the government’s contracts with Randox were awarded improperly”.

The Committee will question senior officials at DHSC and UK Health and Security Agency.

If you have evidence on these issues please submit it here by 6 pm Wednesday 11 May 2022.

This inquiry is no longer accepting evidence

The deadline for submissions was Wednesday 11 May 2022.

Reports, special reports and government responses

View all reports and responses
Seventeenth Report - Government’s contracts with Randox Laboratories Ltd
Inquiry Government’s contracts with Randox Laboratories Ltd
Committees Public Accounts Committee
HC 28
Report
Response to this report
Treasury minutes: Government response to the Committee of Public Accounts on the Seventeenth report from Session 2022-23
HC 28
Government Response
Response to this report
Correspondence to Schillings relating to the Government's contracts with Randox Laboratories Ltd dated 20 October 2022 and 26 July 2022
HC 28
Correspondence
Response to this report
Correspondence from Schillings relating to the Government's Contracts with Randox Laboratories Ltd dated 14 September 2022, 25 and 26 July 2022
HC 28
Correspondence

Oral evidence transcripts

View all oral evidence transcripts
18 May 2022
Inquiry Government’s contracts with Randox Laboratories Ltd
Committees Public Accounts Committee
Oral Evidence
GCL0001 - Government’s contracts with Randox Laboratories Ltd
Witnesses Transparency International UK
Committees Public Accounts Committee
Written Evidence

Contact us

  • Email: pubaccom@parliament.uk
  • Phone: 020 7219 5776 (General enquiries). For all media enquiries please contact Jessica Bridges Palmer bridgespalmerj@parliament.uk / 07917488489
  • Address: Public Accounts Committee, House of Commons, London, SW1A 0AA